Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis

(2015) Edward K. Thomsen et al.   CLINICAL INFECTIOUS DISEASES

Wolbachia lipoproteins: abundance, localisation and serology of Wolbachia peptidoglycan associated lipoprotein and the Type IV Secretion System component, VirB6 from Brugia malayi and Aedes albopictus

(2014) Denis Voronin et al.   Parasites & Vectors

Knowledge and Practice Related to Compliance with Mass Drug Administration during the Egyptian National Filariasis Elimination Program

(2013) Khaled M. Abd Elaziz et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Eotaxin-1 is involved in parasite clearance during chronic filarial infection

(2013) K. Gentil et al.   PARASITE IMMUNOLOGY

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

(2013) Alison Krentel et al.   PLoS Neglected Tropical Diseases

Heightened Measures of Immune Complex and Complement Function and Immune Complex–Mediated Granulocyte Activation in Human Lymphatic Filariasis

(2011) Prakash Senbagavalli et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

WolbachiaLipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis

(2009) Joseph D. Turner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY